Panel rejects Sanofi obesity drug
524641
U.S. regulators should  reject a proposed weight-loss pill called Zimulti because of  concerns it may increase suicidal thinking and depression, an  advisory panel unanimously said on Wednesday.
112661
A U.S. advisory panel  urged the government on Thursday to reject Merck & Co Inc's   latest bid to sell the first cholesterol-lowering drug  without a prescription.
482801
A new obesity wonder drug, Acomplia (rimonabant), makes patients lose 10% of their body weight, according to clinical trials carried out by Sanofi-Aventis, the third largest pharmaceutical company in the world.
252815
The Food and Drug Administration has told a researcher that he cannot be part of an advisory panel that will review the safety of a class of drugs used to treat arthritis and pain.
152719
An advisory panel said that the first drug to enhance the sex drive of women should not be approved because of a lack of information about its long-term safety.
365874
Sanofi&#39;s Acomplia lowers cholesterol, trims waistlines, and blocks brain receptors associated with overeating. On the market by 2006?
606585
Jurors on Friday rejected the claims of a Hollywood producer&#39;s wife who said Botox treatments caused breathing problems, fever, fatigue and severe muscle pain.
671791
Federal regulators did not act on a recommendation from their safety reviewers about the risk of heart attacks for the diabetes drug Avandia.
283181
U.S. regulators have rejected GlaxoSmithKline Plc's  experimental drug gepirone ER for adults with major depression.
568631
BETHESDA, Md.  - U.S. experts said on Wednesday  that companies developing fat-fighting drugs should include  severely obese children in their studies but were less  supportive of targeting moderately overweight adults without  health problems.
12623
The Food and Drug Administration has told a researcher that he cannot be part of an advisory panel that will meet early next year to review the safety of a class of drugs, COX-2 inhibitors, used to treat arthritis and pain.
256331
A US regulatory advisory panel has rejected Procter &amp; Gamble&#39;s female sexual dysfunction patch, saying the potential long-term risks of the hormone treatment outweighed the benefits.
445463
European regulators on Thursday recommended that patients with heart disease or leg pains -- a possible sign of heart problems -- should not take GlaxoSmithKline's diabetes drug Avandia.
139967
A new report by a national health advocacy group calls state and national policies ineffective tools in the war against obesity. The Trust for America&#39;s Health, a nonprofit organization
479138
A U.S. federal judge has denied motions to certify classes of users of osteoporosis drug Fosamax who wanted Merck & Co  to set up a program to monitor them for an ailment involving jaw bone decay.
233492
Shares in drug giant AstraZeneca fall after a US medical panel recommends that regulators reject its new drug Exanta.
73292
Federal advisers rejected Merck &amp; Co.'s quest to become the first American drug maker to sell cholesterol-fighting statins over the counter, saying the company's own studies raised potential health risks while offering modest life-saving benefits.